Most Recent
A judge has ruled in-house counsel at Glencore can't view "highly confidential" documents related to the possible sale by Cargill of its Joe White malt business.
Viterra is blaming several former employees for representations made about malt quality in the lead-up to the $420 million sale of its Joe White business to Cargill Australia in 2013.
A Copyright Tribunal decision that led to substantially lower sound recording licence fees for Foxtel was "beyond the pale" because it compared fees charged to the cable TV giant with those charged to fitness centres, the Full Federal Court heard Wednesday.
The ACCC has scored fines totaling $5.5 million in its case against companies and individuals involved in an alleged cartel over the supply of polycarbonate, a little more than a month before trial kicks off against the alleged mastermind behind the cartel.
Consumer goods giant Reckitt Benckiser has been ordered by the Federal Court to remove all in-store advertising for its Strepfen throat lozenges after a successful interlocutory application by rival iNova Pharmaceuticals.
Cargill has won court approval to amend its pleading against Viterra to include details of a law firm meeting in which Viterra executives allegedly made assurances that there were no quality issues with its malt, more than two months into the trial over the $420 million sale of Viterra's Joe White Maltings business to Cargill in 2013.
Gaming giant Aristocrat Technologies is seeking further documents from rival Ainsworth Game Technology to weigh misleading conduct and passing off claims as it mounts a potential copyright and consumer law case.
Cargill has been ordered to turn over what it describes as "highly confidential" documents related to the possible sale of its malt business, a new revelation in the complex trial over claims Viterra fraudulently concealed crucial information when it sold malt producer Joe White Maltings to Cargill Australia in 2013 for $420 million.
The Australian maker of Difflam has taken UK consumer goods giant Reckitt Benckiser to court over ads for Strepfen that claim the rival lozenges provide 'longer lasting relief' from sore throats.
Aristocrat Technologies is pushing on with its bid for four innovation gaming patents, after a delegate for IP Australia revoked the patents because they amounted to nothing more than 'games and game rules'.